These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 35765

  • 1. Constraints on inferring neurochemical involvement in behavior.
    Dismukes RK.
    Neurosci Res Program Bull; 1978 Dec; 16(4):580-4. PubMed ID: 35765
    [No Abstract] [Full Text] [Related]

  • 2. Functional mechanism of the striatum by integration of nine types of synapses which have at least seven different transmitters.
    Hassler R.
    Int J Neurol; 1979 Dec; 13(1-4):94-116. PubMed ID: 45452
    [No Abstract] [Full Text] [Related]

  • 3. [Neuroleptic parkinsonism and tardive dyskinesia and methods of pharmacologically correcting these pathologic conditions (review)].
    Arushanian EB.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985 Dec; 85(2):269-77. PubMed ID: 2858951
    [No Abstract] [Full Text] [Related]

  • 4. Inhibitory mechanisms in the substantia nigra and the dopamine pathway.
    Straughan DW, James TA.
    Int J Neurol; 1979 Dec; 13(1-4):81-93. PubMed ID: 122391
    [No Abstract] [Full Text] [Related]

  • 5. Neuroanatomical and neurochemical substrate of pleasure.
    Cytawa J, Trojniar W.
    Acta Physiol Pol; 1980 Dec; 31 Suppl 20():85-106. PubMed ID: 6105761
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Interactions of dopaminergic and GABAergic neurotransmission: impact of 6-hydroxydopamine lesions into the substantia nigra of rats.
    Hossain MA, Weiner N.
    J Pharmacol Exp Ther; 1995 Oct; 275(1):237-44. PubMed ID: 7562556
    [Abstract] [Full Text] [Related]

  • 11. Experimental basis of the therapy of Parkinson's disease and the cholinergic-dopaminergic equilibrium in basal brain nuclei.
    Wolfarth S.
    Pol J Pharmacol Pharm; 1976 Oct; 28(5):469-93. PubMed ID: 796834
    [No Abstract] [Full Text] [Related]

  • 12. Dissociable properties of dopamine neurons im the nigrostriatal and mesolimbic dopamine systems.
    Koob GF, Del Fiacco M, Iversen SD.
    Adv Biochem Psychopharmacol; 1977 Oct; 16():589-95. PubMed ID: 560793
    [No Abstract] [Full Text] [Related]

  • 13. [Relation between GABAergic and dopaminergic neurons in the basal ganglia].
    Kemel ML, Gauchy C, Girault JA, Besson JM, Glowinski J.
    Encephale; 1987 Jul; 13 Spec No():169-71. PubMed ID: 3319524
    [No Abstract] [Full Text] [Related]

  • 14. [Morphine-like peptides and dopaminergic pathways].
    Destee A.
    LARC Med; 1981 Dec; 1(3):53-4, 57-8. PubMed ID: 6298510
    [No Abstract] [Full Text] [Related]

  • 15. Chemical transmitter systems in the brain.
    Shute CC.
    Mod Trends Neurol; 1975 Dec; 6():183-203. PubMed ID: 607
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of manipulating pallidal and nigral GABA on striatally-mediated head-turning in the rat [proceedings].
    Crossman AR, Lee LA, Slater P.
    Br J Pharmacol; 1977 Nov; 61(3):483P. PubMed ID: 563262
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.